Literature DB >> 182442

Adenylate cyclase and protein phosphokinase activities in human thyroid. Comparison of normal glands, hyperfunctional nodules and carcinomas.

G Sand, A Jortay, R Pochet, J E Dumont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182442     DOI: 10.1016/0014-2964(76)90034-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  10 in total

Review 1.  Hormonogenetic errors in thyroid tumor.

Authors:  F Monaco; M Andreoli
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

2.  Nodular goiter: effects of surgery and thyroxine medication.

Authors:  K Westermark; C P Persson; H Johansson; F A Karlsson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

4.  Thyrotropin receptor-adenylate cyclase system in plasma membranes from normal and diseased human thyroid glands.

Authors:  P Carayon; M Guibout; S Lissitzky
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

5.  The adenylate cyclase-cyclic AMP-phosphodiesterase system in pathological human thyroid.

Authors:  V Macchia; E Mandato; C Carella; G Pisano; G Biscaglia
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

6.  In vitro and in vivo characterizations of established human follicular carcinoma cell line derived from thyroid cancer: a novel model for well-differentiated thyroid malignant tumor.

Authors:  T Tsuda
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

Review 7.  Biochemistry of thyroid regulation under normal and abnormal conditions.

Authors:  M A Pisarev; D L Kleiman de Pisarev
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

8.  Localization of adenylate cyclase and 5'-nucleotidase activities in human thyroid follicular cells.

Authors:  Y Mizukami; F Matsubara; S Matsukawa
Journal:  Histochemistry       Date:  1982

9.  Decrease of prostaglandin I2 binding sites in thyroid cancer.

Authors:  I Virgolini; M Hermann; H Sinzinger
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

10.  Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP.

Authors:  K Nishio; T Morikage; N Kubota; T Ohmori; Y Takeda; Y Fujiwara; K Miki; K Abe; N Saijo
Journal:  Jpn J Cancer Res       Date:  1992-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.